197 related articles for article (PubMed ID: 3327350)
1. The difficult decision when to discontinue multidrug therapy in leprosy.
Kato L
Acta Leprol; 1987; 5(4):279-82. PubMed ID: 3327350
[No Abstract] [Full Text] [Related]
2. Drug resistance and multi-drug therapy in leprosy.
Chatterjee BR
Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576
[No Abstract] [Full Text] [Related]
3. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
4. Multi-drug therapy in leprosy.
Girdhar BK
Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084
[No Abstract] [Full Text] [Related]
5. Whither short-course chemotherapy for leprosy?
Grosset J
Indian J Lepr; 1997; 69(2):119-20. PubMed ID: 9290962
[No Abstract] [Full Text] [Related]
6. [New trends in the treatment of leprosy].
Koźmińska-Kubarska A
Pol Tyg Lek; 1983 Nov; 38(46):1439-41. PubMed ID: 6374636
[No Abstract] [Full Text] [Related]
7. Skin smear examination in relation to multidrug therapy campaigns.
Bhatia VN
Indian J Lepr; 1987; 59(1):75-9. PubMed ID: 3302062
[No Abstract] [Full Text] [Related]
8. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
9. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
10. New developments in the chemotherapy of leprosy.
Freerksen E
Lepr India; 1983 Jan; 55(1):122-32. PubMed ID: 6348410
[No Abstract] [Full Text] [Related]
11. Problems of multidrug therapy.
Ramu G
Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
[No Abstract] [Full Text] [Related]
12. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
13. Single dose multidrug therapy for single lesion paucibacillry leprosy.
Salafia A
Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
[No Abstract] [Full Text] [Related]
14. Single-dose treatment for paucibacillary leprosy; field implications.
Revankar CR; Pai VV; Samy MS; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
[No Abstract] [Full Text] [Related]
15. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
16. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Pai VV; Bulchand HO; Revankar CR; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
[No Abstract] [Full Text] [Related]
17. Rifampicin resistant leprosy: a review and a research proposal of a pilot study.
Ji B
Lepr Rev; 2002 Mar; 73(1):2-8. PubMed ID: 11969122
[No Abstract] [Full Text] [Related]
18. Treatment regimens for leprosy.
Katoch VM
Indian J Lepr; 2008; 80(4):2p preceding 315. PubMed ID: 20329379
[No Abstract] [Full Text] [Related]
19. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
[TBL] [Abstract][Full Text] [Related]
20. Multidrug therapy--the pathway for global leprosy elimination.
al-Qubati Y; al-Kubati AS
Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
